Blinatumomab in Acute Lymphoblastic Leukemia
1 Pogledi
• 06/15/23
0
0
Ugraditi
administrator
Pretplatnici
In this segment, Dan Douer, MD, and Mark R Litzow, MD, describe the novel immunotherapy agent, blinatumomab.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari